Cingulate Inc
NASDAQ:CING
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cingulate Inc
NASDAQ:CING
|
US |
|
Processa Pharmaceuticals Inc
NASDAQ:PCSA
|
US |
|
Niox Group PLC
LSE:NIOX
|
UK |
|
P
|
PRG Corporation PCL
SET:PRG
|
TH |
|
Amara Holdings Ltd
SGX:A34
|
SG |
|
Broendbyernes IF Fodbold A/S
CSE:BIF
|
DK |
|
Surface Transforms PLC
F:XE4
|
UK |
|
Cisadane Sawit Raya PT
IDX:CSRA
|
ID |
|
IndoSterling Technomedia Tbk PT
IDX:TECH
|
ID |
|
T
|
Trip.com Group Ltd
NASDAQ:TCOM
|
CN |
|
A
|
Annaik Ltd
SGX:A52
|
SG |
|
Q
|
Qualitas Controladora SAB de CV
BMV:Q
|
MX |
Bankruptcy Probability
Cingulate Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cingulate Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cingulate Inc
NASDAQ:CING
|
69.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cingulate Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cingulate Inc has total debt of 7.4m USD. This includes both short-term (6.3m USD) and long-term (1.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
